Note of Concern: Effects of Zinc Supplementation on Markers of Insulin Resistance and
Lipid Profiles in Women with Polycystic Ovary Syndrome: a Randomized,
Double-blind, Placebo-controlled Trial
F. Foroozanfard
1
Department of Gynecology and Obstetrics, School of Medicine, Kashan
University of Medical Sciences, Kashan, I.R. Iran
,
M. Jamilian
2
Department of Gynecology and Obstetrics, School of Medicine, Arak
University of Medical Sciences, Arak, I.R. Iran
,
Z. Jafari
3
Research Center for Biochemistry and Nutrition in Metabolic Diseases,
Kashan University of Medical Sciences, Kashan, I.R. Iran
,
A. Khassaf
3
Research Center for Biochemistry and Nutrition in Metabolic Diseases,
Kashan University of Medical Sciences, Kashan, I.R. Iran
,
A. Hosseini
3
Research Center for Biochemistry and Nutrition in Metabolic Diseases,
Kashan University of Medical Sciences, Kashan, I.R. Iran
,
H. Khorammian
3
Research Center for Biochemistry and Nutrition in Metabolic Diseases,
Kashan University of Medical Sciences, Kashan, I.R. Iran
,
Z. Asemi
3
Research Center for Biochemistry and Nutrition in Metabolic Diseases,
Kashan University of Medical Sciences, Kashan, I.R. Iran
Effects of Zinc Supplementation on Markers of Insulin Resistance and Lipid
Profiles in Women with Polycystic Ovary Syndrome: a Randomized, Double-blind,
Placebo-controlled Trial
Foroozanfard F et al. Exp Clin Endocrinol Diabetes 2015; 123
Since publication of this article, serious concerns have been raised about the integrity of the reported
methods, results and analysis. Responses by the leading author and ethics committees
have been unsatisfactory and inconclusive; we advise readers to interpret the
information presented in the article with due caution.